Clinical Trials

Knee Osteoarthritis (KOA)

Liver Cancer (HCC)


Investors


OTCQB: CBMGRobust product pipelines addressing multiple large market opportunities


Management


CBMG has a research, development and manufacturing team with more than 30 years of relevant experience in China, England, and the USA. CBMG is a leading cell therapy...

 

CBMG in the Press

"The company's HCC liver cancer treatment also targets an enormous market.” MarketWatch, 16/09/2013

  •  
  •  
  •